Skip to main content
Erschienen in: European Radiology 12/2019

27.06.2019 | Hepatobiliary-Pancreas

The diagnostic performance of gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced multi-detector computed tomography in detecting hepatocellular carcinoma: a meta-analysis of eight prospective studies

verfasst von: Jiangfa Li, Jiming Wang, Liping Lei, Guandou Yuan, Songqing He

Erschienen in: European Radiology | Ausgabe 12/2019

Einloggen, um Zugang zu erhalten

Abstract

Aim

The purpose of this study was to determine the relative diagnostic benefit of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA)–enhanced magnetic resonance imaging (MRI) over contrast-enhanced multi-detector computed tomography (CEMDCT) for the detection of hepatocellular carcinoma (HCC).

Methods

Two investigators searched multiple databases from inception to January 8, 2019, for studies comparing Gd-EOB-DTPA-enhanced MRI with CEMDCT in adults suspected of HCC. Two reviewers independently selected studies and extracted data.

Results

Eight studies were included enrolling 498 patients. MRI showed significantly higher sensitivity than CT (0.85 vs. 0.68). There was no significant difference in the specificity of MRI and CT (0.94 vs. 0.93). The negative likelihood ratio and positive likelihood ratio of MRI and CT were not significantly different (0.16 vs. 0.15 and 14.7 vs. 11.2, respectively). The summary receiver operating characteristics (SROC) of MRI was higher than that of CT at 0.96 vs. 0.91. In the subgroup analysis with a lesion diameter below 2 cm, the sensitivity of MRI was significantly higher than that of CT (0.79 vs. 0.46).

Conclusion

Gd-EOB-DTPA-enhanced MRI showed higher sensitivity and overall diagnostic accuracy than CEMDCT especially for hepatocellular carcinoma lesions smaller than 2 cm.

Key Points

• Gd-EOB-DTPA-enhanced MRI can detect small lesions of hepatocellular carcinoma.
• Gd-EOB-DTPA-enhanced MRI showed higher sensitivity and overall diagnostic accuracy than CEMDCT in patients with hepatocellular carcinoma.
• Eight prospective studies showed that Gd-EOB-DTPA-enhanced MRI provides greater diagnostic confidence.
Literatur
1.
Zurück zum Zitat Manini MA, Sangiovanni A, Fornari F et al (2014) Clinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma. J Hepatol 60(5):995–1001CrossRef Manini MA, Sangiovanni A, Fornari F et al (2014) Clinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma. J Hepatol 60(5):995–1001CrossRef
2.
Zurück zum Zitat Kim HD, Lim YS, Han S et al (2015) Evaluation of early-stage hepatocellular carcinoma by magnetic resonance imaging with gadoxetic acid detects additional lesions and increases overall survival. Gastroenterology. 148(7):1371–1382CrossRef Kim HD, Lim YS, Han S et al (2015) Evaluation of early-stage hepatocellular carcinoma by magnetic resonance imaging with gadoxetic acid detects additional lesions and increases overall survival. Gastroenterology. 148(7):1371–1382CrossRef
3.
Zurück zum Zitat Pascolo L, Cupelli F, Anelli PL et al (1999) Molecular mechanisms for the hepatic uptake of magnetic resonance imaging contrast agents. Biochem Biophys Res Commun 257(3):746–752CrossRef Pascolo L, Cupelli F, Anelli PL et al (1999) Molecular mechanisms for the hepatic uptake of magnetic resonance imaging contrast agents. Biochem Biophys Res Commun 257(3):746–752CrossRef
4.
Zurück zum Zitat Yoo SH, Choi JY, Jang JW et al (2013) Gd-EOB-DTPA-enhanced MRI is better than MDCT in decision making of curative treatment for hepatocellular carcinoma. Ann Surg Oncol 20(9):2893–2900CrossRef Yoo SH, Choi JY, Jang JW et al (2013) Gd-EOB-DTPA-enhanced MRI is better than MDCT in decision making of curative treatment for hepatocellular carcinoma. Ann Surg Oncol 20(9):2893–2900CrossRef
5.
Zurück zum Zitat Granito A, Galassi M, Piscaglia F et al (2013) Impact of gadoxetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance on the non-invasive diagnosis of small hepatocellular carcinoma: a prospective study. Aliment Pharmacol Ther 37(3):355–363CrossRef Granito A, Galassi M, Piscaglia F et al (2013) Impact of gadoxetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance on the non-invasive diagnosis of small hepatocellular carcinoma: a prospective study. Aliment Pharmacol Ther 37(3):355–363CrossRef
6.
Zurück zum Zitat Yoon JH, Lee JM, Lee YJ, Lee KB, Han JK (2019) Added value of sequentially performed gadoxetic acid-enhanced liver MRI for the diagnosis of small (10-19 mm) or atypical hepatic observations at contrast-enhanced CT: a prospective comparison. J Magn Reson Imaging 49(2):574–587CrossRef Yoon JH, Lee JM, Lee YJ, Lee KB, Han JK (2019) Added value of sequentially performed gadoxetic acid-enhanced liver MRI for the diagnosis of small (10-19 mm) or atypical hepatic observations at contrast-enhanced CT: a prospective comparison. J Magn Reson Imaging 49(2):574–587CrossRef
7.
Zurück zum Zitat Di Martino M, Marin D, Guerrisi A et al (2010) Intraindividual comparison of gadoxetate disodium-enhanced MR imaging and 64-section multidetector CT in the detection of hepatocellular carcinoma in patients with cirrhosis. Radiology. 256(3):806–816CrossRef Di Martino M, Marin D, Guerrisi A et al (2010) Intraindividual comparison of gadoxetate disodium-enhanced MR imaging and 64-section multidetector CT in the detection of hepatocellular carcinoma in patients with cirrhosis. Radiology. 256(3):806–816CrossRef
8.
Zurück zum Zitat Li J, Li X, Weng J et al (2018) Gd-EOB-DTPA dynamic contrast-enhanced magnetic resonance imaging is more effective than enhanced 64-slice CT for the detection of small lesions in patients with hepatocellular carcinoma. Medicine (Baltimore) 97(52):e13964CrossRef Li J, Li X, Weng J et al (2018) Gd-EOB-DTPA dynamic contrast-enhanced magnetic resonance imaging is more effective than enhanced 64-slice CT for the detection of small lesions in patients with hepatocellular carcinoma. Medicine (Baltimore) 97(52):e13964CrossRef
9.
Zurück zum Zitat Liu X, Jiang H, Chen J, Zhou Y, Huang Z, Song B (2017) Gadoxetic acid disodium-enhanced magnetic resonance imaging outperformed multidetector computed tomography in diagnosing small hepatocellular carcinoma: a meta-analysis. Liver Transpl 23(12):1505–1518CrossRef Liu X, Jiang H, Chen J, Zhou Y, Huang Z, Song B (2017) Gadoxetic acid disodium-enhanced magnetic resonance imaging outperformed multidetector computed tomography in diagnosing small hepatocellular carcinoma: a meta-analysis. Liver Transpl 23(12):1505–1518CrossRef
10.
Zurück zum Zitat Kim BR, Lee JM, Lee DH et al (2017) Diagnostic performance of gadoxetic acid-enhanced liver MR imaging versus multidetector CT in the detection of dysplastic nodules and early hepatocellular carcinoma. Radiology. 285(1):134–146CrossRef Kim BR, Lee JM, Lee DH et al (2017) Diagnostic performance of gadoxetic acid-enhanced liver MR imaging versus multidetector CT in the detection of dysplastic nodules and early hepatocellular carcinoma. Radiology. 285(1):134–146CrossRef
11.
Zurück zum Zitat Joo I, Lee JM, Lee DH, Ahn SJ, Lee ES, Han JK (2017) Liver imaging reporting and data system v2014 categorization of hepatocellular carcinoma on gadoxetic acid-enhanced MRI: comparison with multiphasic multidetector computed tomography. J Magn Reson Imaging 45(3):731–740CrossRef Joo I, Lee JM, Lee DH, Ahn SJ, Lee ES, Han JK (2017) Liver imaging reporting and data system v2014 categorization of hepatocellular carcinoma on gadoxetic acid-enhanced MRI: comparison with multiphasic multidetector computed tomography. J Magn Reson Imaging 45(3):731–740CrossRef
12.
Zurück zum Zitat Inoue T, Kudo M, Komuta M et al (2012) Assessment of Gd-EOB-DTPA-enhanced MRI for HCC and dysplastic nodules and comparison of detection sensitivity versus MDCT. J Gastroenterol 47(9):1036–1047CrossRef Inoue T, Kudo M, Komuta M et al (2012) Assessment of Gd-EOB-DTPA-enhanced MRI for HCC and dysplastic nodules and comparison of detection sensitivity versus MDCT. J Gastroenterol 47(9):1036–1047CrossRef
13.
Zurück zum Zitat Chen L, Zhang L, Bao J et al (2013) Comparison of MRI with liverspecific contrast agents and multidetector row CT for the detection of hepatocellular carcinoma: a meta-analysis of 15 direct comparative studies. Gut. 62(10):1520–1521CrossRef Chen L, Zhang L, Bao J et al (2013) Comparison of MRI with liverspecific contrast agents and multidetector row CT for the detection of hepatocellular carcinoma: a meta-analysis of 15 direct comparative studies. Gut. 62(10):1520–1521CrossRef
14.
Zurück zum Zitat Hanna RF, Miloushev VZ, Tang A et al (2016) Comparative 13-year meta-analysis of the sensitivity and positive predictive value of ultrasound, CT, and MRI for detecting hepatocellular carcinoma. Abdom Radiol (NY) 41(1):71–90CrossRef Hanna RF, Miloushev VZ, Tang A et al (2016) Comparative 13-year meta-analysis of the sensitivity and positive predictive value of ultrasound, CT, and MRI for detecting hepatocellular carcinoma. Abdom Radiol (NY) 41(1):71–90CrossRef
15.
Zurück zum Zitat Duncan JK, Ma N, Vreugdenburg TD, Cameron AL, Maddern G (2017) Gadoxetic acid-enhanced MRI for the characterization of hepatocellular carcinoma: a systematic review and meta-analysis. J Magn Reson Imaging 45(1):281–290CrossRef Duncan JK, Ma N, Vreugdenburg TD, Cameron AL, Maddern G (2017) Gadoxetic acid-enhanced MRI for the characterization of hepatocellular carcinoma: a systematic review and meta-analysis. J Magn Reson Imaging 45(1):281–290CrossRef
16.
Zurück zum Zitat Lee YJ, Lee JM, Lee JS et al (2015) Hepatocellular carcinoma: diagnostic performance of multidetector CT and MR imaging-a systematic review and meta-analysis. Radiology. 275(1):97–109CrossRef Lee YJ, Lee JM, Lee JS et al (2015) Hepatocellular carcinoma: diagnostic performance of multidetector CT and MR imaging-a systematic review and meta-analysis. Radiology. 275(1):97–109CrossRef
17.
Zurück zum Zitat Ye F, Liu J, Ouyang H (2015) Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging and multidetector-row computed tomography for the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis. Medicine (Baltimore) 94(32):e1157CrossRef Ye F, Liu J, Ouyang H (2015) Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging and multidetector-row computed tomography for the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis. Medicine (Baltimore) 94(32):e1157CrossRef
18.
Zurück zum Zitat Guo J, Seo Y, Ren S et al (2016) Diagnostic performance of contrast-enhanced multidetector computed tomography and gadoxetic acid disodium-enhanced magnetic resonance imaging in detecting hepatocellular carcinoma: direct comparison and a meta-analysis. Abdom Radiol (NY) 41(10):1960–1972CrossRef Guo J, Seo Y, Ren S et al (2016) Diagnostic performance of contrast-enhanced multidetector computed tomography and gadoxetic acid disodium-enhanced magnetic resonance imaging in detecting hepatocellular carcinoma: direct comparison and a meta-analysis. Abdom Radiol (NY) 41(10):1960–1972CrossRef
19.
Zurück zum Zitat Roberts LR, Sirlin CB, Zaiem F et al (2018) Imaging for the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis. Hepatology. 67(1):401–421CrossRef Roberts LR, Sirlin CB, Zaiem F et al (2018) Imaging for the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis. Hepatology. 67(1):401–421CrossRef
20.
Zurück zum Zitat Whiting PF, Rutjes AW, Westwood ME et al (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155(8):529–536CrossRef Whiting PF, Rutjes AW, Westwood ME et al (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155(8):529–536CrossRef
21.
Zurück zum Zitat Kim SH, Lee J, Kim MJ et al (2009) Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. AJR Am J Roentgenol 192(6):1675–1681CrossRef Kim SH, Lee J, Kim MJ et al (2009) Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. AJR Am J Roentgenol 192(6):1675–1681CrossRef
22.
Zurück zum Zitat Akai H, Kiryu S, Matsuda I et al (2011) Detection of hepatocellular carcinoma by Gd-EOB-DTPA-enhanced liver MRI: comparison with triple phase 64 detector row helical CT. Eur J Radiol 80(2):310–315CrossRef Akai H, Kiryu S, Matsuda I et al (2011) Detection of hepatocellular carcinoma by Gd-EOB-DTPA-enhanced liver MRI: comparison with triple phase 64 detector row helical CT. Eur J Radiol 80(2):310–315CrossRef
23.
Zurück zum Zitat Maiwald B, Lobsien D, Kahn T, Stumpp P (2014) Is 3-Tesla Gd-EOB-DTPA-enhanced MRI with diffusion-weighted imaging superior to 64-slice contrast-enhanced CT for the diagnosis of hepatocellular carcinoma? PLoS One 9(11):e111935CrossRef Maiwald B, Lobsien D, Kahn T, Stumpp P (2014) Is 3-Tesla Gd-EOB-DTPA-enhanced MRI with diffusion-weighted imaging superior to 64-slice contrast-enhanced CT for the diagnosis of hepatocellular carcinoma? PLoS One 9(11):e111935CrossRef
24.
Zurück zum Zitat Tsurusaki M, Sofue K, Isoda H, Okada M, Kitajima K, Murakami T (2016) Comparison of gadoxetic acid-enhanced magnetic resonance imaging and contrast-enhanced computed tomography with histopathological examinations for the identification of hepatocellular carcinoma: a multicenter phase III study. J Gastroenterol 51(1):71–79CrossRef Tsurusaki M, Sofue K, Isoda H, Okada M, Kitajima K, Murakami T (2016) Comparison of gadoxetic acid-enhanced magnetic resonance imaging and contrast-enhanced computed tomography with histopathological examinations for the identification of hepatocellular carcinoma: a multicenter phase III study. J Gastroenterol 51(1):71–79CrossRef
25.
Zurück zum Zitat Imai Y, Katayama K, Hori M et al (2017) Prospective comparison of Gd-EOB-DTPA-enhanced MRI with dynamic CT for detecting recurrence of HCC after radiofrequency ablation. Liver Cancer 6(4):349–359CrossRef Imai Y, Katayama K, Hori M et al (2017) Prospective comparison of Gd-EOB-DTPA-enhanced MRI with dynamic CT for detecting recurrence of HCC after radiofrequency ablation. Liver Cancer 6(4):349–359CrossRef
26.
Zurück zum Zitat Ahn SS, Kim MJ, Lim JS, Hong HS, Chung YE, Choi JY (2010) Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma. Radiology. 255(2):459–466CrossRef Ahn SS, Kim MJ, Lim JS, Hong HS, Chung YE, Choi JY (2010) Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma. Radiology. 255(2):459–466CrossRef
27.
Zurück zum Zitat Huppertz A, Balzer T, Blakeborough A et al (2004) Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings. Radiology. 230(1):266–275CrossRef Huppertz A, Balzer T, Blakeborough A et al (2004) Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings. Radiology. 230(1):266–275CrossRef
28.
Zurück zum Zitat Imbriaco M, De Luca S, Coppola M et al (2017) Diagnostic accuracy of Gd-EOB-DTPA for detection hepatocellular carcinoma (HCC): a comparative study with dynamic contrast enhanced magnetic resonance imaging (MRI) and dynamic contrast enhanced computed tomography (CT). Pol J Radiol 82:50–57CrossRef Imbriaco M, De Luca S, Coppola M et al (2017) Diagnostic accuracy of Gd-EOB-DTPA for detection hepatocellular carcinoma (HCC): a comparative study with dynamic contrast enhanced magnetic resonance imaging (MRI) and dynamic contrast enhanced computed tomography (CT). Pol J Radiol 82:50–57CrossRef
29.
Zurück zum Zitat Hwang J, Kim SH, Lee MW, Lee JY (2012) Small (</= 2 cm) hepatocellular carcinoma in patients with chronic liver disease: comparison of gadoxetic acid-enhanced 3.0 T MRI and multiphasic 64-multirow detector CT. Br J Radiol 85(1015):e314–e322CrossRef Hwang J, Kim SH, Lee MW, Lee JY (2012) Small (</= 2 cm) hepatocellular carcinoma in patients with chronic liver disease: comparison of gadoxetic acid-enhanced 3.0 T MRI and multiphasic 64-multirow detector CT. Br J Radiol 85(1015):e314–e322CrossRef
30.
Zurück zum Zitat Nishie A, Goshima S, Haradome H et al (2017) Cost-effectiveness of EOB-MRI for hepatocellular carcinoma in Japan. Clin Ther 39(4):738–750 e734CrossRef Nishie A, Goshima S, Haradome H et al (2017) Cost-effectiveness of EOB-MRI for hepatocellular carcinoma in Japan. Clin Ther 39(4):738–750 e734CrossRef
31.
Zurück zum Zitat He X, Wu J, Holtorf AP et al (2018) Health economic assessment of Gd-EOB-DTPA MRI versus ECCM-MRI and multi-detector CT for diagnosis of hepatocellular carcinoma in China. PLoS One 13(1):e0191095CrossRef He X, Wu J, Holtorf AP et al (2018) Health economic assessment of Gd-EOB-DTPA MRI versus ECCM-MRI and multi-detector CT for diagnosis of hepatocellular carcinoma in China. PLoS One 13(1):e0191095CrossRef
Metadaten
Titel
The diagnostic performance of gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced multi-detector computed tomography in detecting hepatocellular carcinoma: a meta-analysis of eight prospective studies
verfasst von
Jiangfa Li
Jiming Wang
Liping Lei
Guandou Yuan
Songqing He
Publikationsdatum
27.06.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 12/2019
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-019-06294-6

Weitere Artikel der Ausgabe 12/2019

European Radiology 12/2019 Zur Ausgabe

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärztinnen und Psychotherapeuten.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.